TD
Telo Genomics Corp.
TDSGF · OTC
$0.03 -18.67% (-$0.01)
1M -50.41%
Market Cap $4.45M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.02
22.2% downside
Current Price
$0.026
Undervalued Fair Value Overvalued
According to Bulios Fair Price, TDSGF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
-
N/A P/E N/A
PEG N/A
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 49.93%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 593.95%
Asset turnover 0.00x
ROA 175.16%
Debt
3 /100
High Current ratio 0.49x
Int. coverage -32.62x
Debt/Equity N/A
Stability
19 /100
Unstable Beta 0.24x
Profitable years 0
EPS volatility 53.29%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TDSGF
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
John Allen Farlinger
Employees
8
Headquarters
Toronto
Upcoming events
27 OCT
Earnings
Upcoming earnings report